WAVE Life Sciences (WVE) Misses Q1 EPS by 4c

WAVE Life Sciences (NASDAQ: WVE) reported Q1 EPS of ($0.29), $0.04 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $9.18 million versus the consensus estimate of $11.95 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• Axis Capital Limited Downgrades Nippon Life India Asset Management Ltd (NAM:IN) to Add (2)
• Blue Star Gold closes final tranche of flow-through private placement